Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SENATE SELECT COMMITTEE ON AGING's FUTURE UNCERTAIN

Executive Summary

SENATE SELECT COMMITTEE ON AGING's FUTURE UNCERTAIN in the wake of the Senate GOP committee reorganization. For the 104th Congress, the committee may be reduced in size, put under the jurisdiction of the Senate Finance Committee or eliminated outright. Since 1989, Sen. Pryor (D-Ark.) has used the select committee as a platform for investigations into the pharmaceutical industry, its drug pricing policies, R&D costs and reimbursement levels, as well as Medicare fraud affecting the elderly. In 1993, the House dropped its Select Committee on Aging, which had a similar mandate; Sen. Cochran (R-Miss.) has previously attacked the Senate committee, seeking to eliminate funding for it in February 1993.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS025460

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel